The USP stipulates qualitative and quantitative biological assays for the determination of the identity and activity of insulin. Insulin products marketed in the United States must, as a rule, comply with these requirements. The test according to USP <121> was established at Labor L+S AG in 2005 and has been inspected by the FDA.
For further information and questions, we are happy to answer your questions at +49 (0)9708/9100-280.
Am 7. und 8. Juli wurde der Neubau der Labor L+S AG eingeweiht. Mehrere Tausend...
Mangelsfeld 4, 5, 6
97708 Bad Bocklet-
Fon: +49 (0)9708/9100-0
Fax: +49 (0)9708/9100-36
In our Infobox, we make additional information on our company, our service portfolio and our QM certification available to you in a download.